Inactive Instrument

Insiders Neuralstem, Inc. Nasdaq

Equities

US64127R4011

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Palisade Bio, Inc. Announces Resignation of Mary Ann Gray as Member of the Board	Mar. 06	CI
Palisade Bio Names Donald Williams as Chairman	Feb. 13	MT
Palisade Bio, Inc. Announces Advisory Board Appointments	Feb. 08	CI
Palisade Bio, Inc. Announces the Appointment of Mitchell Jones, M.D., Ph.D., as Chief Medical Officer	23-09-11	CI
Palisade Bio, Inc. Appoints Mitchell Jones as Chief Medical Officer	23-09-11	CI
Palisade Bio, Inc. Announces Board Appointments	23-02-08	CI
Palisade Bio Appoints Herbert B. Slade MD, FAAAAI as Chief Medical Officer	22-11-18	CI
Palisade Bio, Inc. Terminates Michael Dawson as Chief Medical Officer	22-10-17	CI
Palisade Bio, Inc. Announces Executive Changes	22-10-14	CI
Palisade Bio CEO Thomas Hallam Resigns; CFO JD Finley Named Interim Replacement; Shares Fall	22-10-11	MT
Palisade Bio, Inc. Announces Chief Executive Officer Changes	22-10-11	CI
Palisade Bio, Inc. Appoints Robert McRae as Senior Vice President, Operations and Strategic Development	22-02-15	CI
Palisade Bio, Inc. Launches Clinical Steering Committee	21-06-15	CI
Seneca Biopharma, Inc. Announces Board Changes	21-04-27	CI
Palisade Bio, Inc. Announces Board Changes	21-04-26	CI
Seneca Biopharma, Inc. Announces Appointment of Dane Saglio as Principal Executive Officer	21-03-18	CI
Seneca Biopharma, Inc. Announces Management Changes	21-03-18	CI
Thomas Hallam to Serve as Chief Executive Officer of Seneca Biopharma, Inc	20-12-21	CI
Seneca Biopharma, Inc. Announces Executive Appointments and Key Promotion	20-04-01	CI
Neuralstem, Inc. has Changed its Name to Seneca Biopharma, Inc	19-10-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Neuralstem, Inc. Nasdaq

Equities

US64127R4011

Insiders

Filters